<DOC>
	<DOC>NCT02755090</DOC>
	<brief_summary>This study is a multi-site, double-blinded, randomized, non-inferiority clinical trial of inhaled nitrous oxide with oxygen (N2O/O2) versus intravenous (IV) sedation, with fentanyl and midazolam, for pain management in adult women having a pregnancy termination procedure between 12 and 16 weeks gestational age.</brief_summary>
	<brief_title>Nitrous Oxide Versus Intravenous Sedation for Anesthesia</brief_title>
	<detailed_description>This study will evaluate whether nitrous oxide is a feasible and acceptable alternative to IV sedation for pain management during early second trimester D&amp;E. Primary endpoints will include maximum procedural pain using the visual analog scale (VAS) as well as satisfaction with anesthesia using the Iowa Satisfaction with Anesthesia Scale.</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Nitrous Oxide</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>18 years old or older pregnancy termination at gestational age of 1216 weeks able to read and understand either English or Spanish able to obtain reliable postprocedure transportation contraindications to outpatient pregnancy termination contraindications to nitrous oxide use (such as pernicious anemia, current treatment with bleomycin chemotherapy, active upper respiratory illness, or COPD) intrauterine fetal demise chronic narcotic use known adverse reaction to nitrous oxide, Fentanyl, or Versed</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>nitrous</keyword>
	<keyword>pain</keyword>
</DOC>